| Danaher Corporation. (2/25/19). "Press Release: Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion". Washington, DC. |
2019-02-25 |
| Medigene AG. (2/25/19). "Press Release: European Patent Covering TCR Library Suitable for the Development of Neoantigen-specific TCRs". Martinsried. |
2019-02-25 |
| Lonza Group AG. (2/25/19). "Press Release: Lonza Strengthens Pharma, Biotech and Nutrition Offerings with Aligned Structure and New Executive Committee Appointment". Basel. |
2019-02-25 |
| CRISPR Therapeutics AG. (2/25/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results". Zug & Cambridge, MA. |
2019-02-25 |
| Boehringer Ingelheim. (2/25/19). "Press Release: New Chief Medical Officer Appointed". Ingelheim. |
2019-02-25 |
| Themis Bioscience GmbH. (2/25/19). "Press Release: Themis Bioscience Receives FDA Fast Track Designation for Chikungunya Vaccine Candidate". Vienna. |
2019-02-25 |
| Eppendorf AG. (2/21/19). "Press Release: Thomas Heydler Appointed to the Supervisory Board of Eppendorf AG". Hamburg. |
2019-02-21 |
| HeiScreen GmbH. (2/21/19). "Press Release: Researchers at Heidelberg University Hospital Develop First Marketable Blood Test for Breast Cancer". Düsseldorf & Heidelberg. |
2019-02-21 |
| Evotec AG. (2/20/19). "Press Release: Evotec and Helmholtz Centre Joining Platforms and Forces for Novel Antibiotics". Hamburg & Braunschweig. |
2019-02-20 |
| Calypso Biotech S.A.. (2/20/19). "Press Release: Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases". Amsterdam. |
2019-02-20 |
| BASF AG. (2/20/19). "Press Release: BASF’s Investment into Alchemist Accelerator Promotes Digital Innovations in the Chemical Industry". San Francisco, CA & Ludwigshafen. |
2019-02-20 |
| ADC Therapeutics S.A.. (2/20/19). "Press Release: ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-402 (loncastuximab tesirine) and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma" |
2019-02-20 |
| MorphoSys AG. (2/19/19). "Press Release: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire". Planegg. |
2019-02-19 |
| GT Gain Therapeutics S.A.. (2/19/19). "Press Release: Gain Therapeutics SA Announces Closing of EU 2.5 Million Series A Financing to Develop Novel Brain-Penetrant Non-Competitive Pharmacological Chaperones for Rare Lysosomal Storage Diseases and CNS Indi |
2019-02-19 |
| Roche. (2/19/19). "Press Release: FDA Grants Priority Review to Roche’s Polatuzumab Vedotin in Previously Treated Aggressive Lymphoma". Basel. |
2019-02-19 |
| Roche. (2/19/19). "Press Release: FDA Grants Priority Review to Roche’s Personalised Medicine Entrectinib". Basel. |
2019-02-19 |
| CRISPR Therapeutics AG. (2/19/19). "Press Release: CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement". Zug, Cambridge, MA & Durham, NC. |
2019-02-19 |
| Nabriva Therapeutics plc. (2/19/19). "Press Release: Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. |
2019-02-19 |
| Merck KGaA. (2/19/19). "Press Release: Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method". Darmstadt. |
2019-02-19 |
| France Biotech. (2/19/19). "Press Release: France Biotech Announces Launch of HealthTech Investor Day in Paris on June 25th, 2019". Paris. |
2019-02-19 |
| Sartorius AG. (2/19/19). "Press Release: Sartorius Closes Fiscal 2018 Successfully and Aims to Further Expand". Göttingen. |
2019-02-19 |
| S-Biomedic N.V.. (2/18/19). "Press Release: Microbiome Pioneer S-Biomedic Completes Series A Round with DSM Venturing". Belgium. |
2019-02-18 |
| Curetis N.V.. (2/18/19). "Press Release: Curetis’ Subsidiary Ares Genetics and Qiagen Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance". Vienna, Holzgerlingen & Amsterdam. |
2019-02-18 |
| Merck KGaA. (2/16/19). "Press Release: Pivotal Phase III Data for Bavencio (avelumab) plus Inlyta (axitinib) in Advanced Renal Cell Carcinoma Published in The New England Journal of Medicine [Not intended for US, Canada and UK-based media]". Darmstadt & |
2019-02-16 |
| Bayer AG / Bayer Corporation. (2/15/19). "Press Release: Bayer to Obtain Full Rights to Global Development and Commercialization of Oncology Compounds Vitrakvi (larotrectinib) and BAY 2731954 (LOXO-195)". Whippany, NJ. |
2019-02-15 |
| Hookipa Pharma Inc.. (2/15/19). "Press Release: Hookipa Appoints Michael A. Kelly as Independent Director". New York, NY & Vienna. |
2019-02-15 |
| InflaRx N.V.. (2/14/19). "Press Release: Richard Brudnick to Join InflaRx Board of Directors". Jena. |
2019-02-14 |
| High-Tech Gründerfonds Management GmbH. (2/14/19). "Press Release: Plasmion’ SICRIT Sensor Technology Convinces Investors". |
2019-02-14 |
| Arvelle Therapeutics GmbH. (2/14/19). "Press Release: Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe". Basel. |
2019-02-14 |
| BioMed X GmbH. (2/14/19). "Press Release: Merck and BioMed X Expand Collaboration to Immunology Research". Heidelberg. |
2019-02-14 |
| AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. |
2019-02-14 |
| Codexis, Inc.. (2/14/19). "Press Release: Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria". Redwood City, CA. |
2019-02-14 |
| Vor Biopharma, Inc.. (2/14/19). "Press Release: Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia". Boston, MA. |
2019-02-14 |
| Novartis AG. (2/13/19). "Press Release: Novartis Receives FDA Approval for Egaten for the Treatment of Fascioliasis, a Neglected Tropical Disease". Basel. |
2019-02-13 |
| Lonza Group AG. (2/13/19). "Press Release: Emerald Health Pharmaceuticals and Lonza Announce Agreement for Manufacturing of Novel Cannabinoid-Derived Drug Candidate". San Diego, CA & Basel. |
2019-02-13 |
| ADC Therapeutics S.A.. (2/13/19). "Press Release: ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-402 (loncastuximab tesirine) and Imfinzi (durvalumab) in Multiple Types of Advanced Non-Hodgkin Lymphoma". Lausanne. |
2019-02-13 |
| Sanofi S.A.. (2/12/19). "Press Release: Sanofi Appoints Ameet Nathwani Chief Digital Officer". Paris. |
2019-02-12 |
| Boehringer Ingelheim (Canada) Ltd.. (2/12/19). "Press Release: Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials". Burlington, ON & Markham, ON. |
2019-02-12 |
| Evonik Industries AG. (2/12/19). "Press Release: Evonik more than Doubles Venture Capital to Accelerate Innovation. Evonik Has Launched Its Second Venture Capital Fund with a Volume of €150 Millionmillion". Essen. |
2019-02-12 |
| Genedata AG. (2/12/19). "Press Release: Genedata Releases New Request Management System for Biotherapeutics R&D Processes". Basel. |
2019-02-12 |
| Bruker Corporation. (2/11/19). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2018 Financial Results". Billerica, MA. |
2019-02-11 |
| Spectro Analytical Instruments GmbH. (2/11/19). "Press Release: Spectro Introduces SpectroGreen ICP-OES Analyzer". |
2019-02-11 |
| Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried. |
2019-02-11 |
| Merck KGaA. (2/11/19). "Press Release: FDA Accepts sBLA and Grants Priority Review for Bavencio (avelumab) plus Inlyta (axitinib) for the Treatment of Advanced Renal Cell Carcinoma [Not intended for US, Canada and UK-based media]". Darmstadt. |
2019-02-11 |
| Lonza Group AG. (2/11/19). "Press Release: Lonza’s New Pooled Donor Suspension Hepatocytes Enable the Next Level of Reliability, Robustness and Customizability". Walkersville, MD & Basel. |
2019-02-11 |
| Eurofins. (2/11/19). "Press Release: New Site for Microbiology and DNA Analysis in Bremerhaven. Q-Bioanalytic Strengthens the Eurofins Laboratory Network". |
2019-02-11 |
| Vita 34 AG. (2/8/19). "Press Release: Vita 34 Develops Cell Preparations as the Source Material for Immune Cell Therapies and Becomes Cell Bank". Leipzig. |
2019-02-08 |
| Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]". |
2019-02-08 |
| Sartorius AG. (2/8/19). "Press Release: Andrew Alliance and Sartorius Collaborate to Provide Software-connected Pipettes for Life Science Research". Göttingen & Geneva. |
2019-02-08 |
| Lunaphore Technologies S.A.. (2/7/19). "Press Release: Lunaphore Launches Its First Product LabSat". Lausanne. |
2019-02-07 |
| Evotec AG. (2/7/19). "Press Release: Evotec Mourns Loss of Company Co-founder Prof. Manfred Eigen". Hamburg. |
2019-02-07 |
| Evotec AG. (2/7/19). "Press Release: Evotec and Galapagos Enter into Collaboration in the Field of Fibrosis". Hamburg & Mechelen. |
2019-02-07 |
| Sanofi S.A.. (2/7/19). "Press Release: Sanofi Delivers 2018 Business EPS Growth of 5.1% at CER". Paris. |
2019-02-07 |
| HiberCell Inc.. (2/7/19). "Press Release: HiberCell Launches to Prevent Cancer Relapse and Metastasis with Novel Therapeutics. $60.75M Funding Round Led by ARCH Venture Partners with 6 Dimensions Capital". New York, NY. |
2019-02-07 |
| Altona Diagnostics GmbH. (2/7/19). "Press Release: Altona Diagnostics Receives CE-IVD Mark for HCV RT-PCR Test". Hamburg. |
2019-02-07 |
| 4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. |
2019-02-06 |
| Roche. (2/6/19). "Press Release: Roche Joins the World Federation of Hemophilia Humanitarian Aid Program". Basel. |
2019-02-06 |
| Merck KGaA. (2/6/19). "Press Release: Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline". Darmstadt. |
2019-02-06 |
| Andrew Alliance S.A.. (2/6/19). "Press Release: Andrew Alliance and Waters Corporation Partner to Provide Tailored Tools for LC-MS Research". |
2019-02-06 |
| GlaxoSmithKline plc. (2/6/19). "Press Release: GSK Delivers Sales, Earnings and Cash Flow Growth in 2018". London. |
2019-02-06 |
| InflaRx N.V.. (2/6/19). "Press Release: InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. |
2019-02-06 |
| MacroGenics, Inc.. (2/6/19). "Press Release: MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of Margetuximab". Rockville, MD. |
2019-02-06 |
| Optimapharm d.d.. (2/6/19). "Press Release: Optimapharm Acquires Swiss Denothex and Becomes a Leading European Mid-size Clinical Research Organization". |
2019-02-06 |
| Numares AG. (2/5/19). "Press Release: Numares and Mayo Clinic Laboratories Announce Collaboration to Develop New Diagnostic Tests Using Distinctive Nuclear Magnetic Resonance Technology". Regensburg & Rochester, MN. |
2019-02-05 |
| Xencor, Inc.. (2/5/19). "Press Release: Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech". Monrovia, CA. |
2019-02-05 |
| Genedata AG. (2/5/19). "Press Release: Genedata Announces Bruker as a New Ready-to-Run Partner". Washington, DC. |
2019-02-05 |
| Andrew Alliance S.A.. (2/4/19). "Press Release: Macherey-Nagel GmbH & Co. KG and Andrew Alliance Sign Co-Marketing Agreement". Geneva. |
2019-02-04 |
| Qiagen N.V.. (2/4/19). "Press Release: Qiagen Informatics Solutions Chosen to Support Genomics England’s Bold Five Million Genomes in Five Years Project". Hilden & London. |
2019-02-04 |
| Genedata AG. (2/4/19). "Press Release: New Web-based Genedata Screener Showcases at SLAS2019". Washington, DC. |
2019-02-04 |
| Qiagen N.V.. (2/4/19). "Press Release: Qiagen Reports Results for Fourth Quarter and Full-year 2018". Venlo. |
2019-02-04 |
| ETH Zürich [Florian Meyer]. (2/4/19). "Press Release: Promoting Talents and New Ideas for Food Systems of the Future". |
2019-02-04 |
| CureVac AG. (2/4/19). "Press Release: CureVac Appoints Stefan Mueller, Ph.D., as Vice President Preclinical". Tübingen & Boston, MA. |
2019-02-04 |
| Memo Therapeutics AG. (2/1/19). "Press Release: Memo Therapeutics Announces the Development of a Droplet Sorter Enabling Functional Antibody Screening in a High-Throughput Format". |
2019-02-01 |
| Sirion Biotech GmbH. (2/1/19). "Press Release: Sirion Biotech Expands US Presence in Massachusetts". Cambridge, MA. |
2019-02-01 |
| Virometix AG. (2/1/19). "Press Release: Virometix AG Appoints New CEO". Schlieren. |
2019-02-01 |
| Bayer AG. (1/31/19). "Press Release: Bayer and Kyoto University Form Research Alliance to Discover New Treatment Approaches against Lung Diseases [Not intended for U.S. and UK Media]". Berlin. |
2019-01-31 |
| Hitachi Chemical Co., Ltd.. (1/31/19). "Press Release: Notice Regarding the Stock Acquisition of Apceth Biopharma GmbH, a Contract Manufacturer of Regenerative Medicine Products". |
2019-01-31 |
| Apceth Biopharma GmbH. (1/31/19). "Press Release: Hitachi Chemical Co. Ltd. to Acquire Apceth Biopharma GmbH". Munich. |
2019-01-31 |
| Roche. (1/31/19). "Press Release: Roche Reports Very Strong Results in 2018. Group Sales Increase 7% at Constant Exchange Rates and in Swiss Francs". Basel. |
2019-01-31 |
| MorphoSys AG. (1/31/19). "Press Release: MorphoSys Announces Settlement in Patent Lawsuit with Janssen and Genmab". Planegg. |
2019-01-31 |
| Symrise AG. (1/31/19). "Press Release: Symrise Strengthens Pet Food Activities and Expands US Footprint with Acquisition of ADF/IDF". |
2019-01-31 |
| Curetis N.V.. (1/30/19). "Press Release: Curetis’ Unyvero Application Cartridges Receive Regulatory Approvals in Malaysia and Thailand". Amsterdam & Holzgerlingen. |
2019-01-30 |
| Orphazyme A/S. (1/30/19). "Press Release: Orphazyme Reports Positive Results from Full Data Set of Phase II/III Arimoclomol Tria in Niemann-Pick Disease Type C (NPC)". Copenhagen. |
2019-01-30 |
| Dewpoint Therapeutics. (1/30/19). "Press Release: Dewpoint Therapeutics Launches with $60 Million Series A to Advance Proprietary Platform for Drugging Condensates". Cambridge, MA. |
2019-01-30 |
| Roche. (1/30/19). "Press Release: Roche to Discontinue Phase III CREAD 1 and 2 Clinical Studies of Crenezumab in Early Alzheimer’s Disease (AD) - other Company Programmes in AD Continue". Basel. |
2019-01-30 |
| Lonza Group Ltd.. (1/30/19). "Press Release: Lonza Announces Succession of CEO. Richard Ridinger to Retire
– Marc Funk Appointed CEO – Handover as of 1 March 2019". Basel. |
2019-01-30 |
| AC Immune S.A.. (1/30/19). "Press Release: AC Immune Reports Discontinuation of Phase III CREAD 1 and 2 Studies of Crenezumab in Alzheimer’s Disease". Lausanne. |
2019-01-30 |
| Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Sets Offer Price at 75 Euro per Share (Adhoc-News)". |
2019-01-29 |
| Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Announces Strong Investor Demand and Expected Offer Price (Adhoc-News)". |
2019-01-29 |
| CureVac AG. (1/28/19). "Press Release: CureVac Appoints Dimitris Voliotis, M.D., Dr. med., as Chief Development Officer". Tübingen & Boston, MA. |
2019-01-28 |
| MorphoSys AG. (1/26/19). "Press Release: MorphoSys Announces That Its Patents Were Ruled Invalid in Patent Lawsuit Against Janssen and Genmab (Ad hoc)". Planegg. |
2019-01-26 |
| Genmab A/S. (1/26/19). "Press Release: Genmab Announces that the Patents Asserted against Darzalex in the United States Have Been Declared Invalid by Summary Judgment". Copenhagen. |
2019-01-26 |
| AbbVie Inc.. (1/25/19). "Press Release: AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results". North Chicago, IL. |
2019-01-25 |
| Boehringer Ingelheim. (1/24/19). "Press Release: Boehringer Ingelheim Partners with AMPATH to Scale Up Knowledge, Skills and Training for Healthcare Providers in Kenya". Ingelheim. |
2019-01-24 |
| Boehringer Ingelheim. (1/24/19). "Press Release: Boehringer Ingelheim Launches First Veterinary Vaccines Produced in China". Ingelheim. |
2019-01-24 |
| Merck KGaA. (1/24/19). "Press Release: Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors [Not intended for UK- or US-based media]". Darmstadt. |
2019-01-24 |
| BioNTech AG. (1/23/19). "Press Release: BioNTech to Acquire Antibody Generation Unit of MAB Discovery". Mainz & Munich. |
2019-01-23 |
| Clariant International AG. (1/23/19). "Press Release: Clariant Partners with ExxonMobil and Renewable Energy Group to Advance Cellulosic Biofuel Research". Muttenz, Irving, TX & Ames, IA. |
2019-01-23 |
| Marinomed Biotech AG. (1/23/19). "Press Release: Marinomed Resumes Offer Period of the IPO (Adhoc-News)". |
2019-01-23 |
| Merck KGaA. (1/23/19). "Press Release: Merck and Tencent Announce Collaboration on Intelligent Digital Healthcare Services in China". Chengdu. |
2019-01-23 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 15 16 17 ... 45 46 47 
Date
![Picture [iito] No Content Marketing 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
